top of page

Board of Directors

Headshot.jpg

DAN ADAMS, JD

Chairman, EpiVax Therapeutics

  • LinkedIn
ADG - Headshot.jpg

ANNIE DE GROOT, MD
Co-Founder, CEO & CSO @ EpiVax

  • LinkedIn
Bill_edited.jpg

WILLIAM MARTIN, BA

Co-Founder, COO & CIO @ EpiVax

  • LinkedIn
RL headshot_edited.png

RICHARD LIPKIN, MBA

Managing Director @ Easton Capital
Co-founder of The Catalytic Impact Foundation

  • LinkedIn

ADVISORS

bridon.jpg

DOMINIQUE BRIDON, PHD

CEO, Diaccurate

 

Peptide technology expert with over 35 years of experience

  • LinkedIn
M. Cox.jpg

MANON COX, PHD, MBA

CEO, NextWaveBio

  • LinkedIn

Scientific and strategic direction

J.Lieberman.webp

JUDY LIEBERMAN, MD, PHD

Professor & Chair Immunology, Harvard Medical School

Accomplished immunology expert

E.Ramos.jpg

ELEANOR RAMOS, MD

CMO/COO, Provention Bio

  • LinkedIn

Clinical development and medical affairs specialist

Amy-Rosenberg_edited.jpg

AMY ROSENBERG, MD

Senior Director, EpiVax
Former Division Director, CDER, FDA

  • LinkedIn

Regulatory Veteran

NicoleHeadshot_edited_edited.png

NICOLE RUGGIERO

Former CEO, EpiVax Therapeutics
 

  • LinkedIn

Operation and strategy expert

Chemistry Class

PARTNERS

GreenLight.jpg

GREENLIGHT BIOSCIENCES

Novacellum.png

NOVACELLUM

NYU-Langone.jpg

NYU LANGONE HEALTH

U.Chicago.png

UNIVERSITY OF CHICAGO

MountSinai_IcahnSchool_Logo.jpg

MOUNT SINAI

Brown.jfif

BROWN UNIVERSITY

ITI.png

IMMUNOMIC THERAPEUTICS

SGI.jpg

SYNTHETIC GENOMICS

21stCentury.jfif

21ST CENTURY BIOCHEMICALS

Polypeptide.jpg

POLYPEPTIDE

Image by Mikita Yo

INVESTORS

Morningside-Main-logo-002.jpg

MORNINGSIDE VENTURES

paa_logo4x3.jpg

PRINCETON ALUMNI ANGELS

CatalyticImpactFoundation_logo.jpg

CATALYTIC IMPACT FOUNDATION

EpiVaxLogo_Color_HiRes.jpg

EPIVAX, INC.

Next Wave Bio.png

NEXT WAVE BIO

ANY Seed Fund.png

ACCELERATE NEW YORK SEED FUND

bottom of page